Skip to content

ALIMED

Active Private limited companyfounded 2001active for 25 yearsOrchideeënlaan 24, 1820 SteenokkerzeelKBO/BCE: BE 0474.668.114

Timeline

35 events since 2001

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBmicro format · 32 days before the deadline
2025
Back to profit net €62,733 The net result is €62,733, after one loss-making year.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0474668114
Annual accounts 2024 filed PDFmicro format · 31 days before the deadline
2024
Annual accounts 2023 filed PDFmicro format · 29 days before the deadline
2023
Change of role: , from manager to director holds all the shares · General meeting of 27-11-20235 points ▸
  • General meeting, 27-11-2023
  • holds all the shares
  • Director resignation, (manager)
  • Director appointment, (director (not named in the articles))
  • Registered office clause, Orchideeënlaan 24, 1820 Steenokkerzeel
  • The deed holds 15 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2022 filed PDFmicro format · 26 days before the deadline
2022
Annual accounts 2021 filed PDFmicro format · 37 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 36 days before the deadline
2020
Annual accounts 2019 filed PDFfull format · 31 days before the deadline
2019
Back to profit net €43,857 The net result is €43,857, after 3 loss-making years.
Annual accounts 2018 filed PDFabbreviated format · 33 days before the deadline
2018
Annual accounts 2017 filed PDFabbreviated format · 29 days before the deadline
2017
Weakest financial year net -€29,858 The net result drops to -€29,858, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2016 filed PDFabbreviated format · 31 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 19 days before the deadline
2015
Equity above €150,000 equity €165,671 ▲28.5% After 5 profitable years in a row, equity reaches €165,671.
Annual accounts 2014 filed PDFabbreviated format · 24 days late
2014
Annual accounts 2013 filed PDFabbreviated format · 22 days late
2013
Equity above €100,000 equity €109,800 ▲15.8% After 3 profitable years in a row, equity reaches €109,800.
Annual accounts 2012 filed PDFabbreviated format · 29 days before the deadline
2012
Annual accounts 2011 filed PDFabbreviated format · 21 days before the deadline
2011
Back to profit net €20,791 The net result is €20,791, after one loss-making year.
Annual accounts 2010 filed PDFfull format · 31 days late
2010
Annual accounts 2009 filed PDFabbreviated format · 31 days late
2009
Annual accounts 2008 filed PDFabbreviated format · 53 days late
2008
Annual accounts 2007 filed PDFabbreviated format · 69 days late
2007
Annual accounts 2006 filed PDFfull format · 24 days late
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Annual accounts 2004 filed PDFabbreviated format
2004
Annual accounts 2003 filed PDFabbreviated format
Annual accounts 2002 filed PDFabbreviated format
2002
Annual accounts 2001 filed PDFabbreviated format
2001
Incorporation published on 08-05-2001
First establishment Orchideeënlaan 24, Steenokkerzeel

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

ALIMED was incorporated on 25 April 2001.1 is director of the company, appointed by deed of 30-11-2023.2 Total assets rose from €169,118 in 2018 to €218,153 in 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 30-11-2023
  3. 3National Bank, annual accounts 2018 and 2025

Next steps